{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:59:54Z","timestamp":1790063994817,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03ZZ0806A"],"award-info":[{"award-number":["03ZZ0806A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1055806"],"award-info":[{"award-number":["1055806"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1065330"],"award-info":[{"award-number":["1065330"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["GC6-2013"],"award-info":[{"award-number":["GC6-2013"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["643381"],"award-info":[{"award-number":["643381"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-F4-2011-280873"],"award-info":[{"award-number":["HEALTH-F4-2011-280873"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/OFYIRG\/0001\/2016"],"award-info":[{"award-number":["NMRC\/OFYIRG\/0001\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.coi.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T12:00:17Z","timestamp":1500120017000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["BCG \u2014 old workhorse, new skills"],"prefix":"10.1016","volume":"47","author":[{"given":"M","family":"Gengenbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NE","family":"Nieuwenhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHE","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2017.06.007_bib0510","series-title":"Global Tuberculosis Report 2016","author":"WHO","year":"2016"},{"key":"10.1016\/j.coi.2017.06.007_bib0515","series-title":"End TB Strategy","author":"WHO","year":"2015"},{"key":"10.1016\/j.coi.2017.06.007_bib0520","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.06.007_bib0525","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.coi.2017.06.007_bib0530","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2017.06.007_bib0535","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2017.06.007_bib0540","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.06.007_bib0545","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/IAI.74.1.88-98.2006","article-title":"Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence","volume":"74","author":"Brodin","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0550","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","article-title":"ESX\/type VII secretion systems and their role in host\u2013pathogen interaction","volume":"12","author":"Simeone","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coi.2017.06.007_sbref0555","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1620133114","article-title":"Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions","author":"Conrad","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.06.007_bib0560","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.coi.2017.06.007_bib0565","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","article-title":"Tuberculosis vaccines: time to think about the next generation","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0570","doi-asserted-by":"crossref","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2017.06.007_bib0575","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.coi.2017.06.007_bib0580","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1-IL-2-secreting central memory cells","volume":"190","author":"Lindenstrom","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0585","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guerin \u0394ureC::hly vaccine's superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2017.06.007_sbref0590","first-page":"7","article-title":"Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG \u0394ureC::hly improves protection against tuberculosis","author":"Gengenbacher","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coi.2017.06.007_bib0595","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2017.06.007_bib0600","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.06.007_sbref0605","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.1038\/ncomms13894","article-title":"Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy","volume":"7","author":"Griffiths","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2017.06.007_bib0610","doi-asserted-by":"crossref","first-page":"e113951","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","author":"Nandakumar","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coi.2017.06.007_bib0615","doi-asserted-by":"crossref","first-page":"25837","DOI":"10.1038\/srep25837","article-title":"Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis","volume":"6","author":"Nandakumar","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2017.06.007_bib0620","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.coi.2017.06.007_bib0625","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0630","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis","volume":"178","author":"Stanley","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0635","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.coi.2017.06.007_bib0640","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.4049\/jimmunol.174.9.5687","article-title":"Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0645","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/IAI.72.4.2101-2110.2004","article-title":"Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein","volume":"72","author":"Fulton","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0650","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/eji.201141548","article-title":"Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis","volume":"42","author":"Dorhoi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2017.06.007_sbref0655","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1172\/JCI84978","article-title":"ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo","volume":"126","author":"Kupz","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.06.007_bib0660","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.chom.2015.05.005","article-title":"Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis","volume":"17","author":"Collins","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2017.06.007_bib0665","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chom.2015.05.003","article-title":"Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1","volume":"17","author":"Wassermann","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2017.06.007_bib0670","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2012.06.040","article-title":"Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway","volume":"150","author":"Watson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.coi.2017.06.007_bib0675","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI77014","article-title":"Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection","volume":"125","author":"Tzelepis","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.06.007_bib0680","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","article-title":"The recombinant BCG \u0394ureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation","volume":"211","author":"Saiga","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2017.06.007_bib0685","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2017.06.007_bib0690","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/CVI.00015-11","article-title":"Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens","volume":"18","author":"Johansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0695","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0700","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","article-title":"BCG \u0394zmp1 vaccine induces enhanced antigen specific immune responses in cattle","volume":"32","author":"Khatri","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0705","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/iai.55.7.1641-1646.1987","article-title":"Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes","volume":"55","author":"Geoffroy","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0710","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2017.06.007_bib0715","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394ureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0720","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2017.06.007_bib0725","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1286-4579(99)80077-X","article-title":"Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin","volume":"1","author":"Conradt","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coi.2017.06.007_bib0730","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.06.007_bib0735","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.06.007_bib0740","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.micinf.2016.03.005","article-title":"Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guerin \u0394ureC::hly induces superior protection in a mouse model of subclinical tuberculosis","volume":"18","author":"Gengenbacher","year":"2016","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coi.2017.06.007_bib0745","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0750","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0755","doi-asserted-by":"crossref","first-page":"e78966","DOI":"10.1371\/journal.pone.0078966","article-title":"The tuberculosis vaccine candidate Bacillus Calmette-Guerin \u0394ureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice","volume":"8","author":"Rao","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coi.2017.06.007_bib0760","doi-asserted-by":"crossref","first-page":"e01214","DOI":"10.1128\/mBio.01262-14","article-title":"Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guerin \u0394ureC::hly \u0394pdx1 in mice","volume":"5","author":"Gengenbacher","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.coi.2017.06.007_bib0765","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2017.06.007_bib0770","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","author":"Bottai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG expressing ESX-1 from Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved tuberculosis protection","author":"Groeschel","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2017.06.007_bib0780","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0785","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2001.02500.x","article-title":"An essential role for phoP in Mycobacterium tuberculosis virulence","volume":"41","author":"Perez","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coi.2017.06.007_bib0790","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.ppat.0040033","article-title":"Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP","volume":"4","author":"Frigui","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2017.06.007_bib0795","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2005.02832.x","article-title":"Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant","volume":"141","author":"Infante","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0800","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2015.10.010","article-title":"MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice","volume":"96","author":"Aguilo","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.coi.2017.06.007_sbref0805","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coi.2017.06.007_bib0810","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.72.5.3031-3037.2004","article-title":"Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs","volume":"72","author":"Sampson","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0815","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.73.2.1196-1203.2005","article-title":"Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis","volume":"73","author":"Sambandamurthy","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0820","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2009.05.050","article-title":"Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates","volume":"27","author":"Larsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0825","doi-asserted-by":"crossref","first-page":"e15857","DOI":"10.1371\/journal.pone.0015857","article-title":"Lysine auxotrophy combined with deletion of the secA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis","volume":"6","author":"Hinchey","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2017.06.007_bib0830","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis \u0394RD1 \u0394panCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0835","first-page":"101","article-title":"Management of patients with high sperm DNA damage","volume":"127","author":"Moskovtsev","year":"2008","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.coi.2017.06.007_sbref0840","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","article-title":"ESX secretion systems: mycobacterial evolution to counter host immunity","volume":"14","author":"Groschel","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coi.2017.06.007_bib0845","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2017.06.007_bib0850","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","article-title":"Emerging concepts in tissue-resident T cells: lessons from humans","volume":"36","author":"Thome","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0855","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CVI.00700-13","article-title":"Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination","volume":"21","author":"Aguilo","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0860","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2017.06.007_bib0865","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","article-title":"Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice","volume":"53","author":"Giri","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.coi.2017.06.007_bib0870","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/CVI.00394-14","article-title":"Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice","volume":"21","author":"Derrick","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2017.06.007_sbref0875","first-page":"7","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","author":"Perdomo","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coi.2017.06.007_bib0880","doi-asserted-by":"crossref","first-page":"e1005614","DOI":"10.1371\/journal.ppat.1005614","article-title":"Oral tolerance to environmental mycobacteria interferes with intradermal, but not pulmonary, immunization against tuberculosis","volume":"12","author":"Price","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2017.06.007_bib0885","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism","volume":"213","author":"Aguilo","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2017.06.007_bib0890","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.0800043105","article-title":"Immunization by a bacterial aerosol","volume":"105","author":"Garcia-Contreras","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.06.007_sbref0895","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1038\/ncomms9533","article-title":"Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis","volume":"6","author":"Kaushal","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2017.06.007_bib0900","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2017.06.007_bib0905","doi-asserted-by":"crossref","first-page":"e3769","DOI":"10.1136\/bmj.e3769","article-title":"Vaccine programmes must consider their effect on general resistance","volume":"344","author":"Aaby","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2017.06.007_bib0910","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2017.06.007_bib0915","doi-asserted-by":"crossref","first-page":"i5225","DOI":"10.1136\/bmj.i5225","article-title":"Non-specific immunological effects of selected routine childhood immunisations: systematic review","volume":"355","author":"Kandasamy","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2017.06.007_bib0920","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1016\/j.vaccine.2014.10.041","article-title":"Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis","volume":"32","author":"Kaveh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2017.06.007_bib0925","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1016\/j.coi.2017.06.007_sbref0930","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2017.06.007_sbref0935","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2017.06.007_bib0940","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1586\/14760584.2015.1068124","article-title":"Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy","volume":"14","author":"Zheng","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2017.06.007_bib0945","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","author":"Pichler","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.coi.2017.06.007_bib0950","doi-asserted-by":"crossref","first-page":"39916","DOI":"10.18632\/oncotarget.9537","article-title":"Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guerin therapy in bladder cancer","volume":"7","author":"Pichler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.coi.2017.06.007_bib0955","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.coi.2017.06.007_bib0960","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/BLC-150039","article-title":"Bacillus Calmette-Guerin (BCG) treatment failures with non-muscle invasive bladder cancer: a data-driven definition for BCG unresponsive disease","volume":"2","author":"Steinberg","year":"2016","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.coi.2017.06.007_bib0965","doi-asserted-by":"crossref","first-page":"9859021","DOI":"10.1155\/2016\/9859021","article-title":"Prediction of Bacillus Calmette-Guerin response in patients with bladder cancer after transurethral resection of bladder tumor by using genetic variation based on genomic studies","volume":"2016","author":"Zhang","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.coi.2017.06.007_bib0970","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/jiw228","article-title":"Vaccination against tuberculosis with whole-cell mycobacterial vaccines","volume":"214","author":"Scriba","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2017.06.007_bib0975","doi-asserted-by":"crossref","first-page":"276fs278","DOI":"10.1126\/scitranslmed.aaa4730","article-title":"Tuberculosis vaccines: time for a global strategy","volume":"7","author":"Kaufmann","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2017.06.007_sbref0980","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.06.007_bib0985","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","article-title":"Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-naive adults: A randomized, active-controlled, first-in-human phase 1 trial","volume":"7","author":"Hoft","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2017.06.007_bib0990","series-title":"La vaccination pr\u00e9ventive contre la tuberculose par le \u201cBCG\u201d","author":"Calmette","year":"1927"},{"key":"10.1016\/j.coi.2017.06.007_bib0995","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2017.06.007_bib1000","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.06.007_bib1005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2017.06.007_bib1010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role of antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791516301480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791516301480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:33:27Z","timestamp":1760603607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791516301480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":101,"alternative-id":["S0952791516301480"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2017.06.007","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG \u2014 old workhorse, new skills","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}